Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.
Multiple myeloma (MM) is a malignant plasma cell disorder with poor long-term survival and high recurrence rates. Despite evidence of graft-versus-myeloma (GvM) effects, the use of allogeneic hematopoietic stem cell transplantation (allo-SCT) remains controversial in MM. In the current study, we inv...
Main Authors: | Marilène Binsfeld, Yves Beguin, Ludovic Belle, Eléonore Otjacques, Muriel Hannon, Alexandra Briquet, Roy Heusschen, Pierre Drion, Jenny Zilberberg, Bjarne Bogen, Frédéric Baron, Jo Caers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4240591?pdf=render |
Similar Items
-
Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.
by: Ludovic Belle, et al.
Published: (2016-01-01) -
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors.
by: Eléonore Otjacques, et al.
Published: (2013-01-01) -
Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioning.
by: Muriel De Bock, et al.
Published: (2013-01-01) -
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
by: Margaux Lejeune, et al.
Published: (2021-06-01) -
Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells.
by: Ludovic Belle, et al.
Published: (2012-01-01)